We confirmed that β-catenin and YAP/TAZ were activated in murine and human CAFs (Fig. 5h and Supplementary Figure 7a&b), and in the stroma of breast, colorectal and ovarian cancers (Supplementary Figure 7c). This evidence concerns the gene YAP1 and ovarian carcinoma.